Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study

Objective We describe the demographics, clinical features, disease course, and survival of polyarteritis nodosa (PAN) through an international collaboration (GLOBAL‐PAN). Methods Patients with PAN were recruited between 1990 and 2020 from observational cohorts of nine countries across Europe, Japan,...

Full description

Saved in:
Bibliographic Details
Published inArthritis & Rheumatology Vol. 76; no. 7; pp. 1120 - 1129
Main Authors Ramirez, Giuseppe, Treppo, Elena, Quartuccio, Luca, Pastore, Serena, Martín-Nares, Eduardo, Pagnoux, Christian, Grayson, Peter C., Mohammad, Aladdin J., Ozen, Seza, Emmi, Giacomo, Furuta, Shunsuke, Hinojosa-Azaola, Andrea, Ayan, Gizem, Bolek, Ertugrul Cagri, Hocevar, Alojzija, Warrington, Kenneth J., Karadag, Omer, YAZICI, AYTEN, Seo, Phillip, Kilickap, Saadettin, Kawakami, Tamihiro, Kasifoglu, Timucin, Tufan, Abdurrahman, Karadeniz, Hazan, Kono, Hajime, Springer, Jason, Tezcan, Mehmet Engin, Guido, Jeannin, Gregoni, Gina, Gopaluni, Seerapani, Gazel, Ummugulsum, Forbess, Lindsy, Schiavon, Franco, Felicetti, Mara, Ertenli, Ihsan, Tomsic, Matija, Sánchez-Cubías, Susy Marcela, Conticini, Edoardo, Chung, Sharon, Cefle, Ayse, Bozzola, Enrico, Lopalco, Giuseppe, Vaglio, Augusto, Moreland, Larry, Ugurlu, Serdal, Yazisiz, Veli, Armagan, Berkan, Gercik, Onay, Akar, Servet, Rhee, Rennie, Amudala, Naomi, Merkel, Peter A., Jayne, David, Simonini, Gabriele, Khalidi, Nader A., Padoan, Roberto, Koening, Curry, Langford, Carol A., McAlear, Carol A., Cuthbertson, David, Dagna, Lorenzo, Direskeneli, Haner, Alberici, Federico, Abe, Yoshiyuki, Alibaz-Oner, Fatma, Monti, Sara, Monach, Paul A., Moroni, Luca
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley 01.07.2024
Wiley Periodicals, Inc
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN2326-5191
2326-5205
2326-5205
DOI10.1002/art.42817

Cover

More Information
Summary:Objective We describe the demographics, clinical features, disease course, and survival of polyarteritis nodosa (PAN) through an international collaboration (GLOBAL‐PAN). Methods Patients with PAN were recruited between 1990 and 2020 from observational cohorts of nine countries across Europe, Japan, and North America. Eligibility was retrospectively defined using the European Medicines Agency classification algorithm. Patients with PAN related to hepatitis B virus (n = 12) and two monogenic diseases mimicking PAN, deficiency of adenosine deaminase 2 enzyme (n = 16) or familial Mediterranean fever (n = 11), were excluded. Data regarding organ involvement, relapse, disease‐related damage, and survival were analyzed. Results Three hundred fifty‐eight patients (female:male ratio 174:184), including those with systemic PAN (sPAN, n = 282) and cutaneous PAN (n = 76), were included. Twenty‐five were pediatric onset. Mean ± SD age at diagnosis was 44.3 ± 18.1 years. Constitutional symptoms (71.5%), cutaneous involvement (70.5%), musculoskeletal findings (69.1%), and neurologic features (48.0%) were common manifestations. Among patients with sPAN, gastrointestinal involvement and proteinuria over 400 mg/day were reported in 52.2% and 11.2%, respectively. During a median (interquartile range) 59.6 (99.5) months of follow‐up, relapse occurred in 48.5% of patients. One, 5‐ and 10‐year survival rates for sPAN were 97.1%, 94.0%, and 89.0%, respectively. Predictors of death for sPAN included age ≥65 years at diagnosis, serum creatinine at diagnosis >140 μmol/L, gastrointestinal manifestations, and central nervous system (CNS) involvement. Conclusion The spectrum of PAN remains a complex, multifaceted disease. Relapse is common. Age ≥65 years and serum creatinine >140 μmol/L at diagnosis, as well as gastrointestinal and CNS involvement, are independent predictors of death in sPAN.
Bibliography:Author disclosures and graphical abstract are available at
https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42817
https://onlinelibrary.wiley.com/doi/10.1002/art.42817
Supported by the Vasculitis Clinical Research Consortium, which received funding from the National Center for Advancing Translational Science, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant U54‐AR‐057319), and the National Center for Research Resources (grant U54‐RR‐019497) of the NIH. Dr Jayne's work was supported by the National Institute for Health Research Cambridge Biomedical Research Centre.
.
Additional supplementary information cited in this article can be found online in the Supporting Information section
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:2326-5191
2326-5205
2326-5205
DOI:10.1002/art.42817